{"id":"https://openalex.org/W2092481364","doi":"https://doi.org/10.2174/0929867322666141212120926","title":"Involvement of the P2X7 Purinergic Receptor in Inflammation: An Update of Antagonists Series Since 2009 and their Promising Therapeutic Potential","display_name":"Involvement of the P2X7 Purinergic Receptor in Inflammation: An Update of Antagonists Series Since 2009 and their Promising Therapeutic Potential","alternate_titles":[],"publication_year":2015,"publication_date":"2015-01-20","ids":{"openalex":"https://openalex.org/W2092481364","doi":"https://doi.org/10.2174/0929867322666141212120926","mag":"2092481364","pmid":"https://pubmed.ncbi.nlm.nih.gov/25515510"},"language":"en","primary_location":{"id":"doi:10.2174/0929867322666141212120926","doi":"https://doi.org/10.2174/0929867322666141212120926","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0929867322666141212120926","pdf_url":null,"source":{"id":"https://openalex.org/S33159018","display_name":"Current Medicinal Chemistry","issn_l":"0929-8673","issn":["0929-8673","1875-533X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2092481364"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108078552","display_name":"Davy Baudelet","orcid":"https://orcid.org/0000-0001-7399-1384","observed_orcids":["https://orcid.org/0000-0001-7399-1384"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Davy Baudelet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068389054","display_name":"Emmanuelle Lipka","orcid":"https://orcid.org/0000-0003-2304-2214","observed_orcids":["https://orcid.org/0000-0003-2304-2214"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Emmanuelle Lipka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067704036","display_name":"R\u00e9gis Millet","orcid":"https://orcid.org/0000-0001-7100-6002","observed_orcids":["https://orcid.org/0000-0001-7100-6002"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Regis Millet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5046749913","display_name":"Alina Ghinet","orcid":"https://orcid.org/0000-0001-6468-4331","observed_orcids":["https://orcid.org/0000-0001-6468-4331"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4210128436","display_name":"Lille Inflammation Research International Center","ror":"https://ror.org/03c3m6m66","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I3018718406","https://openalex.org/I4210093160","https://openalex.org/I4210128436","https://openalex.org/I4387152267"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alina Ghinet","raw_affiliation_strings":["INSERM, U995, LIRIC, Universite Lille 2, CHRU de Lille, Faculte de Medecine - Pole Recherche, Place Verdun, F-59045 Lille Cedex, France. alina.ghinet@hei.fr","INSERM, U995, LIRIC, Universite Lille 2, CHRU de Lille, Faculte de Medecine - Pole Recherche, Place Verdun, F-59045 Lille Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM, U995, LIRIC, Universite Lille 2, CHRU de Lille, Faculte de Medecine - Pole Recherche, Place Verdun, F-59045 Lille Cedex, France. alina.ghinet@hei.fr","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I3018718406","https://openalex.org/I4210128436"]},{"raw_affiliation_string":"INSERM, U995, LIRIC, Universite Lille 2, CHRU de Lille, Faculte de Medecine - Pole Recherche, Place Verdun, F-59045 Lille Cedex, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I3018718406","https://openalex.org/I4210128436"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.1613,"has_fulltext":false,"cited_by_count":54,"citation_normalized_percentile":{"value":0.97062326,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"22","issue":"6","first_page":"713","last_page":"729"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11139","display_name":"Gout, Hyperuricemia, Uric Acid","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p2x7-receptor","display_name":"P2X7 receptor","score":0.9950000047683716},{"id":"https://openalex.org/keywords/purinergic-receptors","display_name":"purinergic receptors","score":0.8360000252723694},{"id":"https://openalex.org/keywords/p2x7-antagonists","display_name":"P2X7 antagonists","score":0.9879999756813049},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.7950000166893005},{"id":"https://openalex.org/keywords/anti-inflammatory-agents","display_name":"anti-inflammatory agents","score":0.6880000233650208},{"id":"https://openalex.org/keywords/analgesics","display_name":"analgesics","score":0.6539999842643738},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.8629999756813049},{"id":"https://openalex.org/keywords/neurodegenerative-diseases","display_name":"neurodegenerative diseases","score":0.8550000190734863},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.7570000290870667},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.46299999952316284}],"concepts":[{"id":"https://openalex.org/C57306754","wikidata":"https://www.wikidata.org/wiki/Q1010629","display_name":"Purinergic receptor","level":3,"score":0.9134913682937622},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.8218387961387634},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.5963362455368042},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.544350802898407},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44823214411735535},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4478932321071625},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.44504499435424805},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1102924644947052}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D058486","descriptor_name":"Receptors, Purinergic P2X7","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D058486","descriptor_name":"Receptors, Purinergic P2X7","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D058486","descriptor_name":"Receptors, Purinergic P2X7","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D058920","descriptor_name":"Purinergic P2X Receptor Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D058920","descriptor_name":"Purinergic P2X Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/0929867322666141212120926","doi":"https://doi.org/10.2174/0929867322666141212120926","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0929867322666141212120926","pdf_url":null,"source":{"id":"https://openalex.org/S33159018","display_name":"Current Medicinal Chemistry","issn_l":"0929-8673","issn":["0929-8673","1875-533X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:25515510","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25515510","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1968512491","https://openalex.org/W2029203960","https://openalex.org/W1971620051","https://openalex.org/W4399299471","https://openalex.org/W4362523581","https://openalex.org/W4322761760","https://openalex.org/W4250145760","https://openalex.org/W3153368606","https://openalex.org/W2768734810","https://openalex.org/W4386056661"],"abstract_inverted_index":{"The":[0],"purinergic":[1],"receptor":[2,41],"P2X7":[3,57,76,84],"is":[4],"highly":[5],"expressed":[6],"in":[7,17,29,64,77],"immune":[8,35,79],"peripheral":[9],"and":[10,63,89],"central":[11],"cells":[12],"suggesting":[13],"its":[14],"important":[15],"role":[16],"numerous":[18],"diseases":[19],"characterized":[20],"by":[21],"inflammatory":[22],"processes":[23],"like":[24],"cancer,":[25],"or":[26],"neurodegenerative":[27],"pathologies":[28],"relation":[30],"with":[31],"modulation":[32],"of":[33,39,53,75,83,97],"the":[34,73,78,81,95],"system.":[36],"Thereby,":[37],"antagonization":[38],"this":[40],"may":[42],"be":[43],"a":[44,50],"hopeful":[45],"therapeutic":[46,92],"strategy":[47],"to":[48],"treat":[49],"large":[51],"range":[52],"diseases.":[54,101],"Indeed,":[55],"selective":[56],"antagonists":[58,85],"display":[59],"beneficial":[60],"anti-inflammatory,":[61],"analgesic,":[62],"some":[65],"cases,":[66],"anticancer":[67],"properties.":[68],"This":[69],"article":[70],"will":[71],"review":[72],"involvement":[74],"system,":[80],"update":[82],"series":[86],"since":[87],"2009":[88],"their":[90],"promising":[91],"potential":[93],"for":[94],"treatment":[96],"several":[98],"immune-":[99],"related":[100]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2092481364","counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
